Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00096772 · ClinicalTrials.gov registry record

Collection of Blood Samples From HIV Infected People

A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
2,502
Enrollment target

NCT00096772: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

NCT00096772 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 2,502 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00096772 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
2,502 participants
Enrollment target

Study Summary

The purpose of this study is to collect blood samples from HIV infected individuals for use in future genetic studies.

Trial Details

FieldValue
Enrollment Target 2,502 participants
Start Date 2005-01
Est. Completion 2007-09

What the finished NCT00096772 record still lists

NCT00096772 is an observational study that tracks outcomes without assigning an intervention. Its 2,502 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT00096772 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00096772 about?

NCT00096772 is a clinical study titled "Collection of Blood Samples From HIV Infected People". The purpose of this study is to collect blood samples from HIV infected individuals for use in future genetic studies.

What is the current status of trial NCT00096772?

This trial is currently completed. The enrollment target is 2,502 participants. The study started on 2005-01. Estimated completion is 2007-09.

Who is sponsoring clinical trial NCT00096772?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001160 · 2,500 participants

    Studies on Tumors of the Thyroid

  • NCT01904188 · 2,500 participants

    Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

  • NCT02257229 · 2,500 participants

    Prospective Evaluation of Treatment for Clubfoot

  • NCT02530658 · 2,500 participants

    Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00096772, the US trial registry maintained by the National Library of Medicine. NCT00096772 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.